Comprehensive cardiac resynchronization therapy optimization in the real world

Jan Steffel1, Helene Rempel, Alexander Breitenstein

  • 1Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Switzerland. j.steffel@gmx.ch.

Cardiology Journal
|August 31, 2013
PubMed

Insights

Many cardiac resynchronization therapy (CRT) patients have suboptimal device settings. Expert follow-up is essential for optimizing CRT programming and improving outcomes in chronic heart failure (CHF).

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is vital for reducing morbidity and mortality in chronic heart failure (CHF) patients.
  • Optimal device programming is critical for maximizing patient benefit from CRT.
  • This study evaluated real-world CRT device settings and identified parameters needing adjustment.

Purpose of the Study:

  • To assess device settings in CHF patients undergoing CRT optimization in a real-world setting.
  • To identify which device parameters most frequently require adjustment during CRT optimization.

Main Methods:

  • Analysis of CRT device implantation data from the University Hospital Zurich (Jan 2011 - Sep 2012).
  • Inclusion of all patients with available follow-up data.

Main Results:

  • 170 CHF patients were analyzed; 44% had true biventricular pacing, 49.9% showed QRS fusion.
  • Most patients required atrioventricular (AV) delay adjustments (shortened for QRS fusion, prolonged for A wave truncation).
  • Interventricular delay (VV delay) required less frequent changes (11.9%).

Conclusions:

  • A significant number of patients present with suboptimal CRT device settings post-operatively.
  • The opportunity for device optimization is often missed in routine practice.
  • Expert device follow-up is crucial for optimal patient care in this population.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...